![]() | Up a level |
Journal Article
Hauke, J., Hahnen, E., Burges, A., Reuss, A., Gregorio, N. D., El-Balat, A., Richters, L., Hilpert, F., Schmidt, S., Meier, W., Gevensleben, H., Heubner, M., Dietrich, D., Kast, K., Braicu, E., Neunhoeffer, T., Schmutzler, R. K. and Harter, P. (2018). Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study). Oncol. Res. Treat., 41. S. 90 - 92. BASEL: KARGER. ISSN 2296-5262
Sehouli, J., Mahner, S., Neunhoeffer, T., Harter, P., de Gregorio, N., Fridrich, C., Markmann, S., Richter, R., Potenberg, J., Lorenz, R., Schmidt, M., Doering, G., Belau, A., Lueck, H. J., Chekerov, R., du Bois, A. and Hilpert, F. (2016). Topotecan (T) +/- Sorafenib (S) for platinum-resistant ovarian cancer (PROC): results of doubleblind placebo-controlled randomized NOGGO - AGO intergroup trial. Int. J. Gynecol. Cancer, 26. S. 2 - 4. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1525-1438